Completed OBSERVATIONAL NCT06084325

The Role of Oxytocin and Interoception in Functional Neurological Disorder

Sponsor: Insel Gruppe AG, University Hospital Bern

Conditions Functional Neurological Disorder

Interventions Heartbeat Tracking (HBT) Heartbeat evoked potential (HEP) Libet task Respiration resistance sensitivity task (RRST)

Updated 4 times since 2023 Last updated: Mar 24, 2025 Started: Oct 5, 2023 Primary completion: Jan 24, 2025 Completion: Jan 24, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Functional Neurological Disorder, this trial is completed. The trial is conducted by Insel Gruppe AG, University Hospital Bern and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Apr 2025 — Present [monthly]

Completed

Status: Recruiting → Completed
Sep 2024 — Apr 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Nov 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Oct 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Insel Gruppe AG, University Hospital Bern
University of Fribourg

Data source: University of Fribourg

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bern, Switzerland
• Fribourg, Switzerland